A comparative analysis of vegetative disorders in Parkinson`s disease and vascular parkinsonism.
Objective: Comparative analysis of vegetative disorders (VD) in Parkinson's disease and vascular parkinsonism. Background: Vegetative disorders (VD) are one of the most common nonmotor disorders…Correlation between levels of plasma neurofilament light chain and freezing of gait in Parkinson’s disease
Objective: This study evaluated the correlation between neurofilament light chain (NfL) and freezing of gait (FOG) in Parkinson's disease (PD). Background: PD patients frequently experience…Chromosomal Microarray Analysis for genetic evaluation of dystonia
Objective: To identify copy number variants (CNVs) associated with isolated or combined dystonia in Indian patients using chromosomal microarray analysis (CMA). Background: Chromosomal aberrations, especially…Dynamic assessment of levels of depression and anxiety impairment in Parkinson’s disease
Objective: To dynamic assessment of depression and anxiety disorders in Parkinson's disease. Background: One of the most common nonmotor disturbances in Parkinson's disease (PD) is…Effectiveness of non-invasive therapy of tPCS & peripheral nerve stimulation on Ataxia patients
Objective: A pilot study to determine the effectiveness of a combination of transcranial pulsed current stimulation and pulsed current peripheral nerve stimulation as a novel…Holmes Tremor and Dystonia as Manifestation of Benedikt Syndrome in HIV-Related Cerebral Toxoplasmosis : A Case Report
Objective: To present movement disorder symptoms of Holmes tremor and dystonia as part of Benedikt Syndrome in a patient diagnosed with HIV-Related Cerebral Toxoplasmosis Background:…Glucocerebrosidase (GCase) activator, Ambroxol, reduces alpha-synuclein serine-129 phosphorylation and oligomers in mutant LRRK2 R1441G mouse brains
Objective: To explore whether inducing brain GCase activity by Ambroxol™ (ABX; a brain-penetrant GCase activator) can reduce a-synuclein (αSyn) serine-129 phosphorylation and oligomer accumulation in…Protein X: a key player in Parkinson’s Disease pathophysiology? – insights from compound screening in gba1 knock-out medaka
Objective: This experiment was conducted to elucidate the molecular pathogenesis of Parkinson's disease (PD) and identify potential treatments. Background: PD is one of the most…Validating A New Writer’s Cramp Impairment Scale
Objective: A new writer’s cramp impairment scale (WCIS) was created and is compared with the existing writer’s cramp rating scale (WCRS). Background: Writer’s cramp (WC)…Comparative whole transcriptome analysis of human and mice models of Parkinson’s disease bearing defective glucocerebrosidase activity revealed alteration of expression profile of genes involved in the autophagy
Objective: To identify potential biomarkers of Parkinson's disease (PD) associated with dysfunction of enzyme glucocerebrosidase (GCase) by a comparative whole transcriptome analysis of animal models…
- « Previous Page
- 1
- …
- 216
- 217
- 218
- 219
- 220
- …
- 1554
- Next Page »